Clinical effect and safety evaluation of different dosage of Rituximab combined with Cyclophosphamide in treatment of refractory immune Thrombocytopenia

首页> 外文期刊>Chemical geology >Clinical effect and safety evaluation of different dosage of Rituximab combined with Cyclophosphamide in treatment of refractory immune Thrombocytopenia

【24h】

Clinical effect and safety evaluation of different dosage of Rituximab combined with Cyclophosphamide in treatment of refractory immune Thrombocytopenia

机译：与环磷酰胺相结合的不同剂量与环磷酰胺治疗难治性免疫血小板减少症的临床疗效及安全评价

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: To discuss clinical effect of different dosage of rituximab combined with cyclophosphamide in treatment of refractory immune thrombocytopenia (rITP).

机译：目的：讨论不同剂量利妥昔单抗与环磷酰胺治疗难治性免疫血小板减少症（RITP）的临床疗效。

著录项

来源
《Chemical geology》 |2019年第2019期|共6页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类地球化学;
关键词
Coagulation function; Cyclophosphamide; Lymphocyte; Refractory immune thrombocytopenic purpura; Rituximab; Untoward effect;

机译：凝血功能;环磷酰胺;淋巴细胞;难治性免疫血小板减少紫癜;rituximab;不提供效果;

相似文献

外文文献
中文文献
专利

1. Clinical effect and safety evaluation of different dosage of Rituximab combined with Cyclophosphamide in treatment of refractory immune Thrombocytopenia [J] . Chemical geology . 2019,第期

机译：与环磷酰胺相结合的不同剂量与环磷酰胺治疗难治性免疫血小板减少症的临床疗效及安全评价
2. Efficacy and safety of rituximab in Japanese patients with relapsed chronic immune thrombocytopenia refractory to conventional therapy [J] . Miyakawa Yoshitaka, Katsutani Shinya, Yano Takahiro, International journal of hematology . 2015,第6期

机译：利妥昔单抗在日本常规治疗难以治愈的慢性免疫性血小板减少性复发患者中的疗效和安全性
3. Cyclophosphamide-refractory scleroderma-associated interstitial lung disease: Remarkable clinical and radiological response to a single course of rituximab combined with high-dose corticosteroids [J] . HaroonM., McLaughlinP., HenryM., Therapeutic advances in respiratory disease. . 2011,第5期

机译：环磷酰胺难治性硬皮病相关性间质性肺疾病：单一剂量利妥昔单抗联合大剂量皮质类固醇激素的显着临床和放射学反应
4. Management of refractory immune thrombocytopenia [C] . David C. Lewis Annual Veterinary Medical Forum . 1997

机译：难治性免疫血小板减少症的管理
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Clinical effect and safety evaluation of different dosage of Rituximab combined with Cyclophosphamide in treatment of refractory immune Thrombocytopenia [O] . Zhibin Wang, Yu Ren, Mingwei Li, 2020

机译：不同剂量利妥昔单抗联合环磷酰胺治疗难治性免疫性血小板减少的临床疗效及安全性评价
7. Clinical effect and safety evaluation of different dosage of Rituximab combined with Cyclophosphamide in treatment of refractory immune Thrombocytopenia [O] . Zhibin Wang, Yu Ren, Weibo Huang, 2019

机译：与环磷酰胺相结合的不同剂量与环磷酰胺治疗难治性免疫血小板减少症的临床疗效及安全评价

Clinical effect and safety evaluation of different dosage of Rituximab combined with Cyclophosphamide in treatment of refractory immune Thrombocytopenia

摘要

著录项

相似文献

相关主题

期刊订阅